Quantifying the increasing use of anti-vascular endothelial growth factor therapy in ophthalmology
{{output}}
Introduction: Bevacizumab (Avastin; Genetech Inc., South San Francisco, CA) and ranibizumab (Lucentis, Genetech Inc.) are two anti-Vascular Endothelial Growth Factor (VEGF) agents used in increasing amounts off-label to treat ocu... ...
